期刊文献+

氯化锂对肝癌细胞BEL-7402增殖、周期的影响及其作用机制

Effect of lithium chloride on proliferation and cell cycle of human hepatoma cells
下载PDF
导出
摘要 目的探讨氯化锂对人肝癌细胞BEL-7402增殖、周期的影响及其作用机制。方法应用MTT法及DNA PREP细胞周期法检测BEL-7402经氯化锂作用后的增殖及周期改变情况,Western blot检测糖原合成激酶-3(GSK-3)、失活pGSK-3及其下游分子CyclinD1的表达情况。结果氯化锂可显著抑制BEL-7402的增殖,并呈时间、剂量依赖性(P<0.05);氯化锂可使BEL-7402的G_0/G_1期比例明显降低、G_2/M期比例显著升高(P<0.05);氯化锂作用后GSK-3、失活pGSK-3及CyclinD1蛋白的表达水平均明显升高(P<0.05)。结论氯化锂可抑制肝癌细胞增殖,其机制可能是通过抑制GSK-3活性并上调CyclinD1表达使肝癌细胞阻滞于G_2/M期。 Objective To investigate the effect of lithium chloride (LiCI) on cell proliferation,cell cycle of human hepatoma cells and its mechanism. Methods Cultured human hepatoma BEL-7402 cells were treated with different concentrations of LiCI. Cell proliferation was measured by MTT assay and cell cycle was examined by DNA PREP cell cycle assay. The expressions of GSK-3, inactivated GSK-3 and CyclinD1 were determined by Western blot. Results LiCI inhibited BEL-7402 cell proliferation in a concentration- and time-dependent manner. After LiCI treatment the percentage of G0/G 1 phase was significantly reduced, the G2/M phase was significantly increased, and the expression levels of GSK-3, inactivated GSK-3 and CyclinD1 were up-regulat- ed. Conclusion LiCI can inhibit the proliferation of BEL-7402 cells, in which inactivation of GSK-3 and up-regulation of CyclinD1 may be involved leading to cell cycle arrest in G2/M phase.
出处 《浙江医学》 CAS 2013年第19期1736-1738,1772,共4页 Zhejiang Medical Journal
关键词 肝癌 糖原合成激酶-3 氯化锂 CYCLIND1 Liver cancer Glycogen synthase kinase 3 Lithium chloride CyclinD1
  • 相关文献

参考文献1

二级参考文献11

  • 1赵书君,刘俊英,任芬若,丰有吉.葡萄糖转运蛋白1在卵巢上皮性癌组织中的表达及其与碱性成纤维生长因子、增殖细胞核抗原表达的关系[J].中华妇产科杂志,2005,40(4):264-268. 被引量:10
  • 2Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol,2005, 202: 654-662.
  • 3Jope RS, Johnson GVW. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci, 2004, 29: 95-102.
  • 4Ougolkov AV, Fernandez-Zapico ME, Savoy DN, et al. Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res, 2005, 65:2076-2081.
  • 5Shakoofi A, Ougolkov A, Yu ZW, et al. Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun, 2005,334:1365-1373.
  • 6Meijer L, Flajolet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci, 2004, 25:471-480.
  • 7Gatenby RA, Gawlinski ET. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res, 2003, 63 : 3847-3854.
  • 8Hoeflich KP, Luo J, Rubie EA, et al. Requirement for glycogen synthase kinase-313 in cell survival and NF-κB activation. Nature,2000, 406: 86-90.
  • 9Demarchi F, Bertoli C, Sandy P, et al. Glycogen synthase kinase-313 regulates NF-κB1/p105 stability. J Biol Chem, 2003, 278:39583 -39590.
  • 10于甬华,于金明.正电子发射型计算机断层显像在肿瘤临床中的应用[J].中华肿瘤杂志,2003,25(6):615-617. 被引量:13

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部